SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950123-09-018300
Filing Date
2009-06-29
Accepted
2009-06-29 09:10:01
Documents
3
Effectiveness Date
2009-06-29

Document Format Files

Seq Description Document Type Size
1 CORNERSTONE THERAPEUTICS INC. b75905cte8vk.htm DEFA14A 18342
2 EX-10.2 AMENDMENT TO STOCKHOLDERS AGREEMENT b75905ctexv10w2.htm EX-10.2 12338
3 EX-10.4 AMENDMENT TO AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT - DAVID b75905ctexv10w4.htm EX-10.4 8912
  Complete submission text file 0000950123-09-018300.txt   41132
Mailing Address 1255 CRESCENT GREEN DRIVE SUITE 250 CARY NC 27518
Business Address 1255 CRESCENT GREEN DRIVE SUITE 250 CARY NC 27518 919-678-6611
CORNERSTONE THERAPEUTICS INC (Filer) CIK: 0001145404 (see all company filings)

IRS No.: 043523569 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-50767 | Film No.: 09914507
SIC: 2834 Pharmaceutical Preparations